Perspective Therapeutics (CATX) Non-Current Deferred Tax Liability (2023 - 2026)

Perspective Therapeutics' Non-Current Deferred Tax Liability history spans 4 years, with the latest figure at $1.7 million for Q1 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 31.78% to $1.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.7 million, a 31.78% decrease, with the full-year FY2025 number at $1.7 million, down 31.78% from a year prior.
  • Non-Current Deferred Tax Liability hit $1.7 million in Q1 2026 for Perspective Therapeutics, roughly flat from $1.7 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for CATX hit a ceiling of $4.6 million in Q4 2023 and a floor of $1.7 million in Q4 2025.
  • Historically, Non-Current Deferred Tax Liability has averaged $3.2 million across 4 years, with a median of $2.5 million in 2024.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: crashed 45.67% in 2024 and later crashed 31.78% in 2025.
  • Tracing CATX's Non-Current Deferred Tax Liability over 4 years: stood at $4.6 million in 2023, then crashed by 45.67% to $2.5 million in 2024, then crashed by 31.78% to $1.7 million in 2025, then changed by 0.0% to $1.7 million in 2026.
  • Business Quant data shows Non-Current Deferred Tax Liability for CATX at $1.7 million in Q1 2026, $1.7 million in Q4 2025, and $2.5 million in Q3 2025.